Masimo Announces Limited Market Release of Radius VSM™
Masimo (NASDAQ: MASI) announced today that Radius VSM™, a wearable, tetherless vital signs monitor, has received CE marking and is being released in limited European markets. The versatile, expandable Radius VSM provides the ability to monitor a wide variety of physiological measurements, including continuous SET® pulse oximetry, noninvasive blood pressure, body temperature, respiration rate, and electrocardiography (ECG). Designed on a wearable, modular platform, Radius VSM features can be scaled to accommodate surges in patient volume and for use across the continuum of patient care, based upon each patient’s needs and level of acuity. For additional versatility, Radius VSM can operate as a self-contained device or be used wirelessly with Masimo bedside monitors and patient surveillance systems—automating the integration of expanded monitoring and the transfer of continuous monitoring data to electronic medical records (EMRs).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201101005062/en/
Masimo Radius VSM™ (Photo: Business Wire)
As a comprehensive, scalable solution, Radius VSM has potential clinical utility in a multitude of care scenarios while also encouraging ambulation and freedom of movement, which studies have shown to be a key factor in more rapid patient recovery.1-2 Configurable with a variety of modules and noninvasive sensors designed to prioritize comfort and ergonomics, care teams can seamlessly increase or decrease the technologies monitored based on each patient’s needs, without additional bedside equipment, infrastructure, or tethered connections. Radius VSM offers the following wearable technologies:
- Clinically proven Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry,3 including oxygen saturation (SpO2), pulse rate (PR), perfusion index (Pi), PVi® fluid responsiveness, and RRp® plethysmographic respiration rate
- ECG with heart rate, respiration rate, and advanced lethal arrhythmia detection using 3-leadwire single-patient-use electrodes offering 6 ECG waveforms: I, II, III, aVR, aVL, and aVF
- Measure-on-inflation noninvasive blood pressure that features single-patient-use cuffs, customizable scheduling (eliminating the need for periodic manual clinician measurement), and variable inflation speeds; for example, quicker for ambulating patients and slower for resting patients, minimizing the possibility of sleep disruption
- Continuous body temperature measurements with notifications when clinician-specified temperature thresholds are breached
- RRa® continuous acoustic respiration rate monitoring using rainbow Acoustic Monitoring®, which converts the acoustic patterns caused by the patient’s airflow into breath cycles to calculate respiration rate and visualize an acoustic respiration waveform
Radius VSM features a high-resolution touchscreen and the ability to store and display up to four hours of trend and waveform data on the device itself, providing additional clinical context at the point of care for nurses, therapists, and doctors when interacting directly with patients. In addition, Radius VSM’s rechargeable battery lasts over twelve hours between charges; two devices are supplied for each bedside to provide uninterrupted functionality. Radius VSM has a rugged, durable exterior designed to withstand busy hospital environments and drops of up to one meter, and is water resistant.
Radius VSM can communicate via Bluetooth® to the Root® Patient Monitoring and Connectivity Hub at the bedside, for enhanced visibility on Root’s display. The device can also independently communicate via Wi-Fi to the Patient SafetyNet™ Supplemental Remote Monitoring and Clinician Notification system, enabling use as a patient surveillance system monitored from central viewing stations. The ability to track continuous vital signs and telemetry data from afar is an especially relevant feature for clinicians in the context of COVID-19 and other contagious conditions, where staying informed of patient status while minimizing the risk of cross-contamination can be essential to effective patient care. In addition, automated remote data transfer from Radius VSM to electronic medical records (EMRs) ensures that up-to-date physiological data is always available to clinicians and systems throughout the hospital, without the need for time-consuming manual transcription.
Joe Kiani, Founder and CEO of Masimo, said, “Radius VSM offers the reliability and accuracy of a bedside monitor with the flexibility of a wearable device, thus opening the door to numerous new uses, made possible by its unique scalability and broad range of automated, continuous measurements. We’re excited for clinicians and patients in Europe to experience the advantages of Radius VSM, and look forward to making it available to the rest of the world as regulatory clearances are obtained.”
@Masimo | #Masimo
Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Our mission is to improve patient outcomes and reduce the cost of care. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies.3 Masimo SET® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates,4 improve CCHD screening in newborns,5 and, when used for continuous monitoring with Masimo Patient SafetyNet™ in post-surgical wards, reduce rapid response team activations, ICU transfers, and costs.6-9 Masimo SET® is estimated to be used on more than 200 million patients in leading hospitals and other healthcare settings around the world,10 and is the primary pulse oximetry at 9 of the top 10 hospitals according to the 2020-21 U.S. News and World Report Best Hospitals Honor Roll.11 Masimo continues to refine SET® and in 2018, announced that SpO2 accuracy on RD SET® sensors during conditions of motion has been significantly improved, providing clinicians with even greater confidence that the SpO2 values they rely on accurately reflect a patient’s physiological status. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVi®), RPVi™ (rainbow® PVi), and Oxygen Reserve Index (ORi™). In 2013, Masimo introduced the Root® Patient Monitoring and Connectivity Platform, built from the ground up to be as flexible and expandable as possible to facilitate the addition of other Masimo and third-party monitoring technologies; key Masimo additions include Next Generation SedLine® Brain Function Monitoring, O3® Regional Oximetry, and ISA™ Capnography with NomoLine® sampling lines. Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless, wearable technology, such as Radius-7® and Radius PPG™, portable devices like Rad-67™, fingertip pulse oximeters like MightySat® Rx, and devices available for use both in the hospital and at home, such as Rad-97®. Masimo hospital automation and connectivity solutions are centered around the Masimo Hospital Automation™ platform, and include Iris Gateway®, Patient SafetyNet, Replica™, Halo ION™, UniView™, UniView: 60™, and Masimo SafetyNet™. Additional information about Masimo and its products may be found at www.masimo.com. Published clinical studies on Masimo products can be found at www.masimo.com/evidence/featured-studies/feature/.
ORi and RPVi have not received FDA 510(k) clearance and are not available for sale in the United States. The use of the trademark Patient SafetyNet is under license from University HealthSystem Consortium.
- Needham D et al. Archives of Physical Medicine and Rehabilitation. Vol 91, Issue 4, PP 536–542, April 2010.
- Ronnenbaum J et al. J Acute Care Phys Ther. 2012;3(2):204-210.
- Published clinical studies on pulse oximetry and the benefits of Masimo SET® can be found on our website at http://www.masimo.com. Comparative studies include independent and objective studies which are comprised of abstracts presented at scientific meetings and peer-reviewed journal articles.
- Castillo A et al. Prevention of Retinopathy of Prematurity in Preterm Infants through Changes in Clinical Practice and SpO2 Technology. Acta Paediatr. 2011 Feb;100(2):188-92.
- de-Wahl Granelli A et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ. 2009;Jan 8;338.
- Taenzer A et al. Impact of pulse oximetry surveillance on rescue events and intensive care unit transfers: a before-and-after concurrence study. Anesthesiology. 2010:112(2):282-287.
- Taenzer A et al. Postoperative Monitoring – The Dartmouth Experience. Anesthesia Patient Safety Foundation Newsletter. Spring-Summer 2012.
- McGrath S et al. Surveillance Monitoring Management for General Care Units: Strategy, Design, and Implementation. The Joint Commission Journal on Quality and Patient Safety. 2016 Jul;42(7):293-302.
- McGrath S et al. Inpatient Respiratory Arrest Associated With Sedative and Analgesic Medications: Impact of Continuous Monitoring on Patient Mortality and Severe Morbidity. J Patient Saf. 2020 14 Mar. DOI: 10.1097/PTS.0000000000000696.
- Estimate: Masimo data on file.
This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, statements regarding the potential effectiveness of Masimo Radius VSM™, SET®, and RRa®. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumptions regarding the repeatability of clinical results; risks related to our belief that Masimo's unique noninvasive measurement technologies, including Masimo Radius VSM, SET®, and RRa, contribute to positive clinical outcomes and patient safety; risks related to our belief that Masimo noninvasive medical breakthroughs provide cost-effective solutions and unique advantages; risks related to COVID-19; as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kymeta and OneWeb Partner to Develop Flat Panel User Terminal for LEO Network to Support Land Fixed Solutions Paving the Way to Future Land Mobile, and Maritime Mobility Solutions1.12.2021 13:45:00 CET | Press release
Kymeta (www.kymetacorp.com), the communications company making mobile global, and OneWeb (www.oneweb.world), the Low Earth Orbit (LEO) satellite communications company, announced today a joint development agreement (JDA) to develop an innovative flat panel electronically steered user terminal that is compatible with the OneWeb network to support land fixed applications and leading the way to various mobility applications like land mobile, maritime, and other mobility needs of the future. The Kymeta™ u8 flat panel antenna technology provides an innovative solution to interoperate with the OneWeb LEO satellite constellation that supports Communication on the Pause (COTP) and future Communications on the Move (COTM) for military, government, first responder, maritime, enterprise and other commercial customers. The Kymeta u8 based terminal will provide the benefits of interoperability between GEO and OneWeb LEO services to strengthen the reach of the terminal solutions. “This JDA formulize
Cazoo Launches in France and Germany1.12.2021 13:27:00 CET | Press release
Cazoo (NYSE: CZOO), Europe’s leading online car retailer, which makes buying and selling a car as simple and seamless as ordering any other product online, today announced that it has now launched its service in both France and Germany, delivering better selection, value, transparency, convenience and peace of mind to consumers in mainland Europe when buying their next car. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211201005572/en/ (Photo: Business Wire) Cazoo owns and reconditions its cars to the highest standard before offering them for delivery in just a few days and has hundreds of cars available in France (www.cazoo.com/fr) and Germany (www.cazoo.com/de). With customers able to purchase a car entirely online and have it delivered directly to their door, Cazoo has been referred to as the ‘Amazon of the used car market’. Cazoo customers can review high quality, 360-degree images from the comfort of their home as well
Finsbury Glover Hering and Sard Verbinnen & Co. Complete Merger, Creating Global Strategic Communications Leader1.12.2021 12:30:00 CET | Press release
Following their announcement on October 13, 2021, Finsbury Glover Hering and Sard Verbinnen & Co. (“SVC”) have completed their merger to create the world’s leading strategic communications firm advising clients in navigating critical opportunities and challenges. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211201005402/en/ The firm brings together over 1,000 communications professionals, operating from 25 offices in Asia, Europe, the Middle East and the United States, including its global headquarters in New York. The new firm is a leader in all aspects of strategic communications, including government affairs, corporate reputation, crisis management and transformation and change, as well as the leading force in financial communications worldwide. Its professionals have deep sector knowledge within rapidly growing industries, such as Health, Tech, Food and Agriculture and Renewable Energy, as well as expertise in Diversit
Wella Company Celebrates Its First Year as an Independent Company by Exceeding Growth Targets, Introducing Breakthrough Innovation and Broadening Leadership Capabilities1.12.2021 12:00:00 CET | Press release
Wella Company, a global leader in the $100 billion beauty industry, today celebrates its one-year anniversary as a stand-alone company. Wella Company has a top professional and retail hair, beauty tech and nail portfolio of iconic brands including Wella Professionals, Clairol, OPI, Nioxin, Sebastian Professional and ghd. The Company, founded in Germany in 1880, returned to independent operating status on December 1, 2020, led by global investment firm Kohlberg Kravis and Roberts (“KKR”) investing a majority-equity stake, which they have twice increased over the past year. Wella Company emerged in the midst of the global COVID-19 pandemic, during which almost the entire professional salon industry – the company’s core customer base – was in lockdown. Despite this challenging global environment, the company set its growth strategy, focused on building the operating foundation for stand-alone success, and hired nearly 1,100 people across the globe, including a roster of top beauty, retail
Pioneer Completes Acquisition of Kodoku Studios1.12.2021 10:59:00 CET | Press release
Pioneer Media Holdings Inc. (“Pioneer” or the “Company”) is pleased to announce that, further to its news release dated October 28, 2021, it has completed its acquisition of Kodoku Studios Limited (“Kodoku”). Kodoku is a studio based in London, England, in the business of developing and publishing NFT (or non-fungible token) games. Its current focus is “The Pit,” a platform for gamers to stake their NFTs, which also allows gamers to attempt to increase the inherent value of their NFTs through “NFT warfare” in a “player vs. player” (PVP) gaming arena, anticipated to launch December 3, 2021. Hewie Rattray, CEO of Kokoku commented, “I am positively thrilled by the acquisition of Kodoku by Pioneer. We relish the opportunity to exercise our vision in the NFT gaming market under the guidance of such an innovative company. We eagerly anticipate unifying with the Pioneer trajectory as we push the frontiers of the metaverse to new limits.” In consideration of all of the securities of Kodoku, th
ATG to Use Ethical Hackers to Rein in Cybersecurity Challenges in Partnership With YesWeHack1.12.2021 10:00:00 CET | Press release
YesWeHack, Europe’s leading bug bounty platform has partnered with Sweden headquartered ATG, to identify potential vulnerabilities on its exposed assets. ATG provides quality excitement and entertainment through horse betting, sports betting and casino games for approximately 1.4 million customers. ATG is constantly evolving to meet new technology demands, increased data access, faster connections, and new digital channels. It is at the forefront of using digital technology to offer content-rich, personalised, and constantly available entertainment while meeting stricter regulation, digitalisation, and higher customer demands. Like other industries that retain extensive customer data, the sports betting and gambling industry is particularly vulnerable to cyber threats. In addition to the games themselves, ATG maintains databases that contain a wealth of private and financial information. It has payment systems and apps that hackers can target. Meanwhile, one of the most significant cha
Nordic Enterprises Embrace Cloud Services to Improve Customer Experience1.12.2021 10:00:00 CET | Press release
Enterprises in the Nordic region are increasing their spending on public cloud services and digital transformation to improve customer experiences, according to a new report published today by Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm. The 2021 ISG Provider Lens™Public Cloud – Services & Solutions Report for the Nordics finds enterprises in the region also increasing cloud spending to expand their product and service portfolios across the globe. In response, public cloud service providers are focused on improving their digital transformation advisory services. Cloud spending in the Nordics has increased across all industry verticals over the last five to six quarters. “Enterprises in the Nordic region have embraced the cloud and emerging digital technologies to become more cost effective and enhance customer experience,” said Jan Erik Aase, partner and global leader, ISG Provider Lens Research. “Companies are also looking for
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom